ImageneBio (IMA) Net Shares Issued and Repurchased (2021 - 2025)
ImageneBio's (IMA) quarterly Net Shares Issued and Repurchased came in at $1.1 million in Q1 2025, down 37.95% year-over-year from $1.8 million in Q1 2024, and down 52.11% quarter-over-quarter from $2.4 million in Q4 2024.
Analysis
ImageneBio (IMA) Net Shares Issued and Repurchased (2021 - 2025) Analysis & Trends
ImageneBio has disclosed Net Shares Issued and Repurchased across 5 years of filings, most recently posting $1.1 million for Q1 2025.
- In Q1 2025, Net Shares Issued and Repurchased fell 37.95% year-over-year to $1.1 million; the TTM figure through Mar 2025 stood at $1.1 million (down 37.95% YoY), while the FY2024 annual figure was $2.4 million, up 35.82% from the prior year.
- Net Shares Issued and Repurchased came in at $1.1 million for Q1 2025 at ImageneBio, down from $2.4 million in the prior quarter.
- In the past five years, Net Shares Issued and Repurchased ranged from a high of $3.4 million in Q4 2021 to a low of $876524.0 in Q1 2022.
- Average Net Shares Issued and Repurchased over 5 years is $1.9 million, with a median of $1.8 million recorded in 2024.
- Year-over-year, Net Shares Issued and Repurchased sank 63.08% in 2022 and jumped 56.41% in 2023.
- Over 5 years, Net Shares Issued and Repurchased stood at $3.4 million in 2021, then tumbled by 43.89% to $1.9 million in 2022, then fell by 9.2% to $1.8 million in 2023, then soared by 35.82% to $2.4 million in 2024, then slumped by 52.11% to $1.1 million in 2025.
- Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $1.1 million in Q1 2025, $2.4 million in Q4 2024, and $1.8 million in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | ImageneBio | 42.89 Mn | -92.46 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 1.14 Mn |
| Dec 31, 2024 | 2.38 Mn |
| Mar 31, 2024 | 1.83 Mn |
| Dec 31, 2023 | 1.75 Mn |
| Mar 31, 2023 | 1.37 Mn |
| Dec 31, 2022 | 1.93 Mn |
| Mar 31, 2022 | 876,524.00 |
| Dec 31, 2021 | 3.44 Mn |
| Mar 31, 2021 | 2.37 Mn |